<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">ZANAMIVIR</span><br/>(zan'a-mi-vir)<br/><span class="topboxtradename">Relenza<br/></span><b>Classifications:</b> <span class="classification">antiinfective</span>; <span class="classification">antiviral</span><br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>5 mg/Rotadisk blister</p>
<h1><a name="action">Actions</a></h1>
<p>Inhibitor of influenza A and B viral enzyme; does not permit the release of newly formed viruses from the surface of the infected
         cells.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Indicated by relief of flu-like symptoms. The inhibition of the viral neuroaminidase enzyme prevents the viral spread across
         the mucus lining of the respiratory tract, and inhibits the replication of influenza A and B virus.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Uncomplicated acute influenza in patients symptomatic 
      </p><h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to zanamivir.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Concurrent use of inhaled medication with inhaled zanamivir; pregnancy (category B), lactation. Safety and efficacy in children
         
      </p><h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Acute Influenza</span><br/><span class="rdage">Adult/</span><span class="rdage">Child &gt;7 y:</span> <span class="rdroute">Inhaled</span> 2 inhalations (one 5 mg blister/inhalation) b.i.d. (approximately 12 h apart) times 5 d<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Inhalation</span><br/><ul>
<li>Initiate within 48 h of onset of flu-like symptoms.</li>
<li>Give scheduled inhaled bronchodilator before zanamivir.</li>
<li>Store at 25° C (77° F).</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Headache. <span class="typehead">CNS:</span> Dizziness. <span class="typehead">GI:</span> Nausea, diarrhea, vomiting. <span class="typehead">Respiratory:</span> Nasal symptoms, bronchitis, cough, sinusitis; ear, nose, throat infection. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> No clinically significant interactions established. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> 417% of inhaled dose is systemically absorbed. <span class="typehead">Peak:</span> 12 h. <span class="typehead">Distribution:</span> Metabolism: Not metabolized. <span class="typehead">Elimination:</span> Excreted in urine.  <span class="typehead">Half-Life:</span> 2.55.1 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Start within 48 h of onset of flu-like symptoms for most effective response.</li>
<li>Use any scheduled inhaled bronchodilator first; then use zanamivir.</li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>